Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,504.00    -48.00 (-3.09%)
Bid:
1,500.00
Ask:
1,506.00
Spread: 6.00 (0.40%)
Market Cap: £782.58m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Director/PDMR Shareholding

15 Dec 2021 10:26

RNS Number : 7491V
M. P. Evans Group PLC
15 December 2021
 

M.P. EVANS GROUP PLC

("Company" or "M.P. Evans")

 

GRANT OF SHARE OPTIONS

 

On 14 December 2021, in line with its policy of deferring half the executive annual bonus into nil-cost share options, the Company granted an option under the M.P. Evans Group PLC Long Term Incentive Scheme to Mr Matthew Coulson, the Finance Director. He may subscribe for 13,748 shares of 10p each in the Company at a nil cost exercise price. No additional performance criteria will attach to the deferred-bonus award since the original bonus is performance related. This option is exercisable at any time between 14 December 2024 and 13 December 2031.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Matthew Coulson

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Shares of 10p per share in the capital of M.P. Evans Group PLC (10p shares)

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over 10p shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes

Nil Cost Options

13,748

d)

Aggregated information

- Aggregated volume

- Price

Aggregated volume: N/A

Price: N/A

e)

Date of the transaction

14 December 2021

f)

Place of the transaction

Outside a trading venue

 

Enquiries:

 

M.P. Evans Group PLC

+44 (0)1892 516333

Peter Hadsley-Chaplin

Executive chairman

Matthew Coulson

Finance director

Peel Hunt LLP (Nomad and joint broker)

+44 (0)20 7418 8900

Dan Webster

Andrew Clark

finnCap (Joint broker)

+44 (0)20 7220 0500

Tim Redfern

Harriet Ward

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack

Elfie Kent

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFIFSIEFSEEE
Date   Source Headline
20th Sep 20237:00 amRNSPublication of TCFD report
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20232:41 pmRNSAIM Rule 20 Notice
12th Sep 20237:00 amRNSTransaction in Own Shares
11th Sep 20237:29 amRNSShare buyback extension
11th Sep 20237:00 amRNSHalf-year Report
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSAcquisition
5th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20237:00 amRNSTransaction in Own Shares
29th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSNotice of interim results & investor presentation
17th Aug 20237:00 amRNSTransaction in Own Shares
16th Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20237:00 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 20237:00 amRNSAppointment of new director
31st Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSTransaction in Own Shares
21st Jul 20237:00 amRNSTransaction in Own Shares
20th Jul 20237:00 amRNSTransaction in Own Shares
20th Jul 20237:00 amRNSCrop and production update
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSTransaction in Own Shares
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:05 amRNSTransaction in Own Shares
12th Jul 20237:05 amRNSCorrective announcement and Total voting rights
7th Jul 202311:27 amRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSDirector/PDMR Shareholding
3rd Jul 202312:08 pmRNSTotal Voting Rights
3rd Jul 20239:12 amRNSBlock listing Interim Review
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.